Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

A Novel BODIPY-Dinitrophenylhydrazine "Off-On" Hypochlorite Ion Fluorescent Probe Based on ICT Mechanism.

Created on 30 Jun 2026

Authors

Zhenbo Liu, Rui Hu, Xiaofang Luan, Junqiang Leng, Linying Yuan, Yanying Zhao, Shudi Liu

Published in

Luminescence : the journal of biological and chemical luminescence. Volume 41. Issue 7. Pages e70556.

Abstract

Hypochlorite (ClO-) plays a crucial role as a significant biological substance in the body. In this work, a fluorescent probe BODIPY-DP was designed based on the ICT mechanism for the detection of ClO-, using BODIPY as the fluorophore group and a C=N double bond linked to 2,4-dinitrophenylhydrazine as the recognition group. The fluorescence intensity of the probe shows a good linear relationship with ClO- concentration, with a linear correlation coefficient (R2) of 0.9945 and a detection limit of 7.38 μM. BODIPY-DP was found to exhibit good selectivity toward ClO-. The fluorescence intensity increases rapidly within 30 s after the addition of ClO-. The spiked recoveries in the determination of ClO- concentration in the disinfectant solutions were found to range from 93.8% to 108.0%. BODIPY-DP exhibits favorable cytocompatibility and proves highly effective for the detection of exogenous ClO- in living HepG2 cells. The findings of this study provide a new means for revealing the role of ClO- in biological processes.

PMID:
42377979
Bibliographic data and abstract were imported from PubMed on 30 Jun 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 3
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement